Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy

Area of Science:

• Urology
• Oncology
• Radiation Oncology

Background:

• Approximately 15% of prostate cancer patients present with lymph node metastases at radical prostatectomy (RP).
• Current treatment strategies for these patients lack a universally accepted standard of care.
• Treatment options range from observation to adjuvant androgen deprivation therapy (aADT) and radiation therapy (RT).

Purpose of the Study:

• To review current treatment options for men with node-positive prostate cancer after RP.
• To highlight the need for robust clinical trials to establish a standard of care.

Main Methods:

• Systematic review of existing literature.
• Analysis of treatment outcomes, including all-cause mortality.
• Discussion of clinical trial design considerations.

Main Results:

• A recent systematic review indicated no definitive best treatment choice among current options.
• Studies suggest adjuvant radiation therapy is associated with lower all-cause mortality compared to salvage radiation therapy.
• There is an urgent need for well-designed clinical trials to guide treatment decisions.

Conclusions:

• Establishing a standard of care for node-positive prostate cancer post-RP is critical.
• Future clinical trials should incorporate observation as a control arm.
• Evidence suggests potential survival benefits with adjuvant radiation therapy in specific patient groups.